|
UBXN4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.207290E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.122900E-03 |
| Normal-vs-Stage2 |
8.04000000000915E-05 |
| Normal-vs-Stage3 |
2.61290000003189E-06 |
| Normal-vs-Stage4 |
1.840440E-04 |
| Stage1-vs-Stage2 |
2.100200E-02 |
| Stage1-vs-Stage3 |
7.501600E-03 |
| Stage1-vs-Stage4 |
1.472750E-01 |
| Stage2-vs-Stage3 |
7.259200E-01 |
| Stage2-vs-Stage4 |
4.322400E-01 |
| Stage3-vs-Stage4 |
5.586800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.023070E-04 |
| Normal-vs-AfricanAmerican |
1.001590E-01 |
| Normal-vs-Asian |
1.936290E-02 |
| Caucasian-vs-AfricanAmerican |
3.694400E-01 |
| Caucasian-vs-Asian |
3.841200E-01 |
| AfricanAmerican-vs-Asian |
8.300800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.09300000000901E-05 |
| Normal-vs-Female |
3.561500E-04 |
| Male-vs-Female |
4.703400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.951760E-02 |
| Normal-vs-Age(41-60Yrs) |
2.46579999999552E-05 |
| Normal-vs-Age(61-80Yrs) |
2.76909999996633E-06 |
| Normal-vs-Age(81-100Yrs) |
1.419640E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.600230E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.583200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.492400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.230200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.751000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.634000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.542000E-01 |
| Classical-VS-Follicular |
8.20360000000075E-05 |
| Classical-VS-Other |
7.716000E-01 |
| Classical-VS-Normal |
6.021700E-03 |
| Tall-VS-Follicular |
2.051600E-01 |
| Tall-VS-Other |
7.524000E-01 |
| Tall-VS-Normal |
3.816800E-03 |
| Follicular-VS-Other |
3.503200E-01 |
| Follicular-VS-Normal |
1.72369999995592E-06 |
| Other-VS-Normal |
1.648840E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.69568999999203E-05 |
| Normal-vs-N1 |
4.085000E-03 |
| N0-vs-N1 |
2.740800E-01 |
|
|
